MedPath

Ecole Polytechnique Fédérale de Lausanne

Ecole Polytechnique Fédérale de Lausanne logo
🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

15

Active:2
Completed:4

Trial Phases

1 Phases

Not Applicable:14

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials

Not Applicable
14 (100.0%)

Novel Individualized Brain Stimulation, Network-based Approaches to Improve Cognition in Healthy Seniors and MCI Patients

Not Applicable
Completed
Conditions
Mild Cognitive Impairment (MCI)
Healthy Aging
First Posted Date
2025-07-29
Last Posted Date
2025-08-07
Lead Sponsor
Ecole Polytechnique Fédérale de Lausanne
Target Recruit Count
61
Registration Number
NCT07090681
Locations
🇨🇿

CEITEC, Brno, Czechia

🇨🇭

Campus Biotech, Geneva, Switzerland

Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease

Not Applicable
Recruiting
Conditions
Hypotension Symptomatic
Parkinson's Disease
Orthostatic Hypotension, Dysautonomic
Multiple System Atrophy (MSA) With Orthostatic Hypotension
Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
First Posted Date
2025-04-09
Last Posted Date
2025-07-25
Lead Sponsor
Ecole Polytechnique Fédérale de Lausanne
Target Recruit Count
5
Registration Number
NCT06920134
Locations
🇨🇭

CHUV, Lausanne, Vaud, Switzerland

Study on Preliminary Safety and Efficacy of Epidural Electrical Stimulation to Manage Lower Urinary Tract Dysfunction After Spinal Cord Injury

Not Applicable
Recruiting
Conditions
Spinal Cord Injuries (SCI)
Spinal Cord Injury
First Posted Date
2025-02-25
Last Posted Date
2025-07-14
Lead Sponsor
Ecole Polytechnique Fédérale de Lausanne
Target Recruit Count
3
Registration Number
NCT06845904
Locations
🇨🇭

Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Vaud, Switzerland

Study on Preliminary Safety and Efficacy of the ARC-IM Therapy to Alleviate Locomotor Deficits in People With Parkinson's Disease

Not Applicable
Recruiting
Conditions
Parkinson Disease
First Posted Date
2024-03-06
Last Posted Date
2025-07-11
Lead Sponsor
Ecole Polytechnique Fédérale de Lausanne
Target Recruit Count
6
Registration Number
NCT06295614
Locations
🇨🇭

Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Vaud, Switzerland

Brain Controlled Spinal Cord Stimulation in Participants with Spinal Cord Injury for Lower Limb Rehabilitation

Not Applicable
Recruiting
Conditions
Paraplegia
Spinal Cord Injuries
First Posted Date
2024-02-06
Last Posted Date
2024-10-01
Lead Sponsor
Ecole Polytechnique Fédérale de Lausanne
Target Recruit Count
3
Registration Number
NCT06243952
Locations
🇨🇭

CHUV, Lausanne, Vaud, Switzerland

  • Prev
  • 1
  • 2
  • 3
  • Next

News

Aging Impairs CAR-T Cell Therapy Effectiveness Through Metabolic Decline, Swiss Study Reveals

New research from Swiss institutions demonstrates that age-related immune decline significantly reduces the effectiveness of CAR-T cell cancer therapy by impairing mitochondrial function and metabolism.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.